×
About 2,645 results

ALLMedicine™ Heparin-induced Thrombocytopenia Center

Research & Reviews  876 results

Heparin-induced thrombocytopenia post-cardiovascular interventional therapy: a case rep...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351125
BMC Cardiovascular Disorders; Shen L, Liu X et. al.

Aug 4th, 2022 - Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse drug reaction characterized by thrombocytopenia and thromboembolism. Herein, we present a case of HIT with subcutaneous hemorrhage after cardiovascular interventional therapy. ...

Heparin-induced thrombocytopenia in an obese pregnant woman with venous thrombosis.
https://doi.org/10.1080/01443615.2022.2106558
Journal of Obstetrics and Gynaecology : the Journal of Th... Kozak M, Vižintin Cuderman T et. al.

Aug 2nd, 2022 - Heparin-induced thrombocytopenia in an obese pregnant woman with venous thrombosis.|2022|Kozak M,Vižintin Cuderman T,Božič-Mijovski M,Lučovnik M,Tratar G,|

Early Administration of Heparin at FMC for PPCI of STEMI Patients
https://clinicaltrials.gov/ct2/show/NCT05329155

Aug 2nd, 2022 - This study will recruit 944 STEMI patients undergoing primary PCI with the symptom onset within 12 hours in 20 hospitals in Hubei Province, China. The patients will be 1:1 randomly assigned to the intervention group (IG) and control group (CG). Pa...

Temporal presentations of heparin-induced thrombocytopenia following cardiac surgery: a...
https://doi.org/10.1111/jth.15826
Journal of Thrombosis and Haemostasis : JTH; Warkentin TE, Sheppard JI et. al.

Jul 24th, 2022 - Heparin-induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery-associated HIT oc...

Anticoagulation with nafamostat mesilate during extracorporeal life support.
https://doi.org/10.1016/j.ijcard.2022.07.022
International Journal of Cardiology; Lang Y, Zheng Y et. al.

Jul 20th, 2022 - Nafamostat mesylate (NM) affects coagulation and fibrinolysis and impedes obesity-associated protein demethylase activity, which regulates Na+/K+ transport properties and the NF-κB signaling pathway. NM significantly decreases macrophage, neutroph...

see more →

Guidelines  2 results

American Society of Hematology 2018 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258919
Blood Advances; Cuker A, Arepally GM et. al.

Nov 30th, 2018 - Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet factor 4 and heparin. Patients are at markedly increased risk of thromboembolism. These evidence-based ...

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest...
https://doi.org/10.1378/chest.08-0677
Chest Warkentin TE, Greinacher A et. al.

Jul 24th, 2008 - This chapter about the recognition, treatment, and prevention of heparin-induced thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th E...

see more →

Drugs  45 results see all →

Clinicaltrials.gov  47 results

Early Administration of Heparin at FMC for PPCI of STEMI Patients
https://clinicaltrials.gov/ct2/show/NCT05329155

Aug 2nd, 2022 - This study will recruit 944 STEMI patients undergoing primary PCI with the symptom onset within 12 hours in 20 hospitals in Hubei Province, China. The patients will be 1:1 randomly assigned to the intervention group (IG) and control group (CG). Pa...

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate Safety and Efficacy of Danaparoid vs Argatroban
https://clinicaltrials.gov/ct2/show/NCT03809481

Jul 20th, 2022 - Objectives: Primary: To show that for the treatment of subjects with acute heparin-induced thrombocytopenia (HIT) danaparoid use is not inferior to argatroban in terms of efficacy. The primary efficacy endpoint (composite endpoint) is defined as t...

EMR Tool Impact on HIT Documentation and Management
https://clinicaltrials.gov/ct2/show/NCT05439265

Jun 30th, 2022 - Heparin-induced thrombocytopenia is a unique form of drug induced thrombocytopenia associated with increased clotting risk. The incidence of HIT ranges from 0.1% to 5%. Heparin-induced thrombocytopenia occurs when an antibody forms a complex with ...

Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
https://clinicaltrials.gov/ct2/show/NCT05382078

May 19th, 2022 - CRRT, the continuous renal replacement therapy, is widely applied in the field of intensive care medicine. This technology is known as an alternative therapy to save injured kidney with advantages of the accurate volume control, stable acid-alkali...

Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
https://clinicaltrials.gov/ct2/show/NCT05237843

Feb 14th, 2022 - Recurrent pregnancy loss (RPL) remains a significant challenge in obstetrical practice. It is not only emotionally devastating for expectant women but is also medically challenging. Approximately 1-3% of women have recurrent spontaneous abortion, ...

see more →

News  87 results

Aiming for System Improvement While Transitioning to the New Normal
https://www.mdedge.com/jcomjournal/article/252976/hospital-medicine/aiming-system-improvement-while-transitioning-new
Ebrahim Barkoudah, MD, MPH

Mar 21st, 2022 - As we transition out of the Omicron surge, the lessons we’ve learned from the prior surges carry forward and add to our knowledge foundation. Medical journals have published numerous research and perspectives manuscripts on all aspects of COVID-19.

A Practical and Cost-Effective Approach to the Diagnosis of Heparin-Induced Thrombocytopenia: A Single-Center Quality Improvement Study
https://www.mdedge.com/jcomjournal/article/252968/hospital-medicine/practical-and-cost-effective-approach-diagnosis-heparin
Alice Cusick, MD, Sarah Hanigan, PharmD et. al.

Mar 21st, 2022 - From the Veterans Affairs Ann Arbor Healthcare System Medicine Service (Dr. Cusick), University of Michigan College of Pharmacy, Clinical Pharmacy Service, Michigan Medicine (Dr.

Enoxaparin-Induced Hemorrhagic Bullae at Sites of Trauma and Endothelial Pathology
https://www.mdedge.com/dermatology/article/247860/wounds/enoxaparin-induced-hemorrhagic-bullae-sites-trauma-and-endothelial
Michael L. Garner, MD, Laura G. Pruitt, MD et. al.

Oct 25th, 2021 - To the Editor: A 67-year-old man with diabetes mellitus was admitted to the hospital for exacerbation of congestive heart failure and atrial flutter with rapid ventricular response. He subsequently developed a non-ST segment elevation myocardial i.

Organs From Deceased Recipients of AstraZeneca COVID-19 Vaccine May Pose Problems
https://www.medscape.com/viewarticle/955225

Jul 23rd, 2021 - NEW YORK (Reuters Health) - Organs from deceased donors who had received AstraZeneca's ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 may possibly prompt vaccine-induced thrombosis and thrombocytopenia (VITT) in recipients, according to a new study. A...

Thrombosis With Thrombocytopenia After mRNA COVID-19 Vaccine
https://www.medscape.com/viewarticle/953901

Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA COVID-19 vaccine has been reported. The case repor...

see more →

Patient Education  1 results see all →